Edition:
United States

Alvogen Korea Co Ltd (002250.KS)

002250.KS on Korea Stock Exchange

28,250.00KRW
22 May 2017
Change (% chg)

₩-50.00 (-0.18%)
Prev Close
₩28,300.00
Open
₩28,250.00
Day's High
₩28,300.00
Day's Low
₩28,150.00
Volume
6,777
Avg. Vol
24,231
52-wk High
₩41,650.00
52-wk Low
₩21,450.00

Latest Key Developments (Source: Significant Developments)

Alvogen Korea to buy back shares at 50 bln won
Friday, 7 Apr 2017 05:35am EDT 

Alvogen Korea Co Ltd <002250.KS> : Says it will repurchase 1.7 million common shares . Says repurchase amount is 50 billion won .Says repurchase period from April 10 to May 2.  Full Article

Alvogen Korea to close production line
Monday, 25 Jul 2016 04:32am EDT 

Alvogen Korea <002250.KS> Co.,Ltd: Says it will suspended the operation of its production line .The suspended amount is 57.62 billion won.  Full Article

ALVOGEN KOREA Co Ltd Appoints Graham Baker as Chief Financial Officer
Thursday, 1 Oct 2015 04:25am EDT 

ALVOGEN KOREA Co Ltd:Says that Kevin Bain, the Company's Chief Financial Officer since 2009 will take on the role of Chief Financial Officer of Alvogen's biotech sister company, Alvotech and continue as EVP of Strategic Development at Alvogen.  Full Article

Keunwha Pharmaceutical announces name change
Tuesday, 16 Jun 2015 05:28am EDT 

Keunwha Pharmaceutical Co Ltd:To change its name to ALVOGEN KOREA, effective June 19.  Full Article

More From Around the Web

BRIEF-Alvogen Korea to buy back shares at 50 bln won

April 7 Alvogen Korea Co Ltd : * Says it will repurchase 1.7 million common shares * Says repurchase amount is 50 billion won * Says repurchase period from April 10 to May 2 Source text in Korean: https://goo.gl/SsmnCs Further company coverage: (Beijing Headline News)

No consensus analysis data available.